血液透析カテーテル市場：世界の産業規模・シェア・動向・機会・予測 (コンポーネント別、材料別、用途別、エンドユーザー別、地域別)、競合情勢 (2020～2030年)

世界の血液透析カテーテルの市場規模は2024年に16億3,000万米ドルで、2030年には25億1,000万米ドルに達すると予測され、CAGRは7.44%です。

血液透析カテーテルの世界市場は、慢性腎臓病と末期腎臓病の世界の有病率の増加に牽引され、大きな成長を遂げています。腎疾患の早期診断とタイムリーな治療に対する意識の高まりが血液透析の需要拡大につながり、カテーテルの採用を後押ししています。先進国でも新興国でも、医療システムは透析治療へのアクセス改善に重点を置いており、そのため血管アクセス用の一時的カテーテルやトンネル型カテーテルの使用が拡大しています。カテーテルのデザイン強化、感染リスクの低減、製品寿命の延長を目指した技術革新も、予測期間中の市場拡大を後押ししています。腎障害の影響を受けやすい高齢化人口の増加は、効率的な血液透析装置の必要性をさらに高め、市場の見通しを強めています。

市場を形成する主な動向は、血流を改善し、血栓症を最小限に抑え、カテーテル関連血流感染の発生率を低下させる、改良された材料とコーティングを備えた先進的な血液透析カテーテルの開発です。メーカーは、患者の安全性と快適性を向上させるため、生体適合性と抗菌性に優れたコーティングに注力しています。医療機器メーカーと医療提供者の協力関係の強化により、患者のさまざまな要求に合わせた革新的な製品の導入が促進されています。また、在宅透析の増加により、患者や介護者が信頼性が高く、使い勝手がよく、耐久性に優れたバスキュラーアクセスソリューションを求めているため、カテーテルの使用にも新たな機会が生まれています。研究開発への投資と新型カテーテルの承認が製品パイプラインを強化し、医療従事者が患者固有の課題に効果的に対処できるようになっています。

成長が見込まれるとはいえ、市場はカテーテル使用に伴う感染、血栓症、機械的合併症のリスクの高さなどの課題に直面しています。規制当局の承認プロセスが厳しいため新製品の導入が遅れ、メーカーにとっては障壁となっています。腹膜透析や腎移植など、血液透析に代わる選択肢は、特に医療インフラが整っている地域では、カテーテルの需要を制限する可能性があります。医療システムに対するコスト圧力や低コストの代替品の利用可能性も、高級カテーテル製品の採用を妨げる可能性があります。しかし、継続的な製品革新、透析患者層の拡大、新興市場における世界企業の投資拡大が、こうした課題を緩和し、世界血液透析カテーテル市場の成長モメンタムを維持すると期待されます。

主な市場促進要因

慢性腎臓病（CKD）および末期腎不全（ESRD）の有病率の上昇

主な市場課題

感染症および血栓症の高リスク

主な市場動向

トンネル型カテーテルの採用増加

目次

第1章 概要

第2章 分析手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の血液透析カテーテル市場の展望

• 市場規模・予測
  • 金額ベース
• 市場シェア・予測
  • コンポーネント別（カテーテル、カテーテルキット）
  • 材料別（ポリウレタン、シリコン）
  • 用途別（慢性腎臓病（CKD）、急性腎不全（AKI））
  • エンドユーザー別（病院、透析センター、外来手術センター（ASC）、在宅医療）
  • 企業別（2024年）
  • 地域別
• 市場マップ

第6章 北米の血液透析カテーテル市場の展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の血液透析カテーテル市場の展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋の血液透析カテーテル市場の展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の血液透析カテーテル市場の展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの血液透析カテーテル市場の展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 企業合併・買収 (M&A)
• 製品上市
• 最近の動向

第13章 混乱：紛争、パンデミック、貿易障壁

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Manish Medi Innovation
• Advin Health Care
• Medical Components, Inc.
• Becton, Dickinson and Company
• Tianck Medical Co., Ltd.
• Mozarc Medical Holding LLC
• Joline GmbH & Co. KG
• Merit Medical Systems, Inc.
• Teleflex Incorporated
• B. Braun SE

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Hemodialysis Catheters Market was valued at USD 1.63 Billion in 2024 and is expected to reach USD 2.51 Billion by 2030 with a CAGR of 7.44%. The Global Hemodialysis Catheters Market is witnessing significant growth driven by the increasing prevalence of chronic kidney disease and end-stage renal disease worldwide. Rising awareness about early diagnosis and timely treatment of renal disorders is leading to greater demand for hemodialysis procedures, thereby boosting the adoption of catheters. Healthcare systems are placing emphasis on improving access to dialysis treatment in both developed and developing economies, which has expanded the usage of temporary and tunneled catheters for vascular access. Technological innovations aimed at enhancing catheter design, reducing infection risks, and extending product lifespan are also supporting market expansion during the forecast period. The growing aging population, which is more vulnerable to renal disorders, further amplifies the need for efficient hemodialysis devices, strengthening the market outlook.

A major trend shaping the market is the development of advanced hemodialysis catheters with improved materials and coatings that offer better blood flow, minimize thrombosis, and lower the incidence of catheter-related bloodstream infections. Manufacturers are focusing on biocompatible and antimicrobial coatings to improve patient safety and comfort. Increasing collaborations between medical device companies and healthcare providers are facilitating the introduction of innovative products tailored for different patient requirements. The rise in home-based dialysis procedures has also created new opportunities for catheter usage, as patients and caregivers demand reliable, user-friendly, and durable vascular access solutions. Investments in R&D and regulatory approvals of new catheter models are strengthening the product pipeline, enabling healthcare providers to address patient-specific challenges more effectively.

Despite the growth prospects, the market faces challenges such as the high risk of infections, thrombosis, and mechanical complications associated with catheter use. Stringent regulatory approval processes can delay the introduction of new products, creating barriers for manufacturers. Alternatives to hemodialysis, including peritoneal dialysis and kidney transplantation, can limit catheter demand, especially in regions with advanced healthcare infrastructure. Cost pressures on healthcare systems and the availability of low-cost alternatives may also hinder adoption of premium catheter products. However, continuous product innovation, expanding dialysis patient pool, and rising investments by global players in emerging markets are expected to mitigate these challenges and sustain the growth momentum of the Global Hemodialysis Catheters Market.

Key Market Drivers

Rising Prevalence of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD)

The increasing global prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) is creating a sustained demand for hemodialysis catheters, making this factor one of the strongest growth drivers for the market. CKD is a progressive condition that affects kidney function over time, and in its most severe form ESRD patients require renal replacement therapy in the form of dialysis or kidney transplantation to survive. Hemodialysis continues to be the dominant mode of treatment, and catheters play an essential role by offering quick and reliable vascular access. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), more than 35.5 million adults in the United States, representing 15% of the adult population, are estimated to be living with CKD. The same source highlights that more than 808,000 individuals in the U.S. are affected by ESRD, and nearly 68% of them rely on dialysis as their primary treatment. These figures emphasize the sheer scale of the population dependent on catheter-based hemodialysis solutions.

Beyond the United States, the burden of CKD is rising globally at an alarming rate. According to recent estimates published in peer-reviewed studies drawing on international health surveillance data, nearly 674 million people worldwide were living with CKD in 2021, which represents around 8.5% of the world's population. This surge has been attributed to an increase in risk factors such as diabetes, hypertension, obesity, and cardiovascular conditions, which often coexist and accelerate the progression of kidney disease. An aging global population also contributes to this growth, as elderly individuals are more likely to experience renal impairment. The expanding dialysis patient pool highlights a persistent and growing reliance on hemodialysis catheters, particularly in situations requiring immediate initiation of treatment. The magnitude of these statistics illustrates how the rising prevalence of CKD and ESRD underpins a consistent and long-term driver for the Global Hemodialysis Catheters Market.

Key Market Challenges

High Risk of Infections and Thrombosis

One of the most critical challenges in the Global Hemodialysis Catheters Market is the high risk of infections and thrombosis associated with their use. Hemodialysis catheters provide direct access to the bloodstream, which makes them an effective solution for vascular access but also exposes patients to significant clinical complications. Catheter-related bloodstream infections remain a major concern in dialysis treatment because even with sterile insertion techniques and advanced antimicrobial coatings, the risk of microbial colonization and biofilm formation on catheter surfaces persists. Such infections often lead to prolonged hospital stays, increased use of antibiotics, and in severe cases, sepsis that can be life-threatening. Thrombosis is another serious issue that compromises catheter performance and patient safety. Blood clot formation inside or around the catheter can reduce blood flow, interfere with dialysis efficiency, and necessitate frequent interventions such as thrombolytic therapy or catheter replacement. These complications not only increase healthcare costs but also contribute to patient discomfort and reduced quality of life.

Despite technological advancements, infection and thrombosis remain common causes of catheter failure and contribute significantly to morbidity and mortality among dialysis patients. Healthcare providers often view catheters as a temporary solution because of these risks, preferring alternative access methods such as arteriovenous fistulas or grafts when possible. The persistence of these clinical challenges highlights the need for continuous innovation in catheter design, materials, and maintenance protocols. Research into antimicrobial biomaterials, infection-resistant coatings, and improved catheter insertion techniques is ongoing, but widespread adoption is limited by regulatory hurdles and cost constraints. Addressing the dual challenge of infections and thrombosis remains a top priority for manufacturers and healthcare providers, as overcoming these risks is essential for improving patient outcomes and strengthening the long-term viability of hemodialysis catheters in clinical practice.

Key Market Trends

Increasing Adoption of Tunneled Catheters

The Global Hemodialysis Catheters Market is witnessing a notable shift toward the increasing adoption of tunneled catheters, driven by their clinical advantages and suitability for long-term dialysis patients. Unlike non-tunneled catheters, which are typically used in emergency or short-term cases, tunneled catheters are placed under the skin and secured in a way that reduces infection risks while offering greater stability. This design makes them preferable for patients who require vascular access over extended periods, especially those awaiting the maturation of arteriovenous fistulas or grafts. Healthcare providers recognize that tunneled catheters deliver more consistent blood flow rates and reduce complications such as kinking or dislodgement, which improves the overall efficiency of dialysis sessions. The demand is also being fueled by technological enhancements such as antimicrobial coatings, heparin bonding, and advanced lumen designs that minimize thrombosis and extend catheter life. With the global prevalence of end-stage renal disease rising, the need for reliable long-term vascular access has become a priority, and tunneled catheters meet this requirement effectively.

Patient comfort and safety are equally influencing adoption, as tunneled catheters are less intrusive for daily activities compared to temporary options. Increasing investments by manufacturers in product innovation and the development of catheters with enhanced biocompatibility are further strengthening their market presence. In many regions, healthcare authorities and practitioners are adopting tunneled catheters as a preferred access method due to their ability to reduce hospital readmissions associated with catheter-related bloodstream infections. The growing focus on personalized care, where treatment strategies are tailored to patient profiles, is also encouraging clinicians to opt for tunneled catheters for individuals requiring prolonged dialysis therapy. This trend is expected to remain a critical driver of product demand during the forecast period, positioning tunneled catheters as a central element of modern dialysis management.

Key Market Players

• Manish Medi Innovation
• Advin Health Care
• Medical Components, Inc.
• Becton, Dickinson and Company
• Tianck Medical Co., Ltd.
• Mozarc Medical Holding LLC
• Joline GmbH & Co. KG
• Merit Medical Systems, Inc.
• Teleflex Incorporated
• B. Braun SE

Report Scope:

In this report, the Global Hemodialysis Catheters Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hemodialysis Catheters Market, By Component:

• Catheter
• Catheter Kit

Hemodialysis Catheters Market, By Material:

• Polyurethane
• Silicone

Hemodialysis Catheters Market, By Application:

• Chronic Kidney Disease (CKD)
• Acute Kidney Injury (AKI)

Hemodialysis Catheters Market, By End User:

• Hospitals
• Dialysis Centers
• Ambulatory Surgical Centers (ASCs)
• Home Healthcare

Hemodialysis Catheters Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hemodialysis Catheters Market.

Available Customizations:

Global Hemodialysis Catheters Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Hemodialysis Catheters Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Catheter, Catheter Kit)
  • 5.2.2. By Material (Polyurethane, Silicone)
  • 5.2.3. By Application (Chronic Kidney Disease (CKD), Acute Kidney Injury (AKI))
  • 5.2.4. By End User (Hospitals, Dialysis Centers, Ambulatory Surgical Centers (ASCs), Home Healthcare)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Hemodialysis Catheters Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By Material
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Hemodialysis Catheters Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By Material
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico Hemodialysis Catheters Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By Material
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada Hemodialysis Catheters Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By Material
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Hemodialysis Catheters Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Material
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Hemodialysis Catheters Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Material
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Hemodialysis Catheters Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Material
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Hemodialysis Catheters Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Material
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Hemodialysis Catheters Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Material
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Hemodialysis Catheters Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Material
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Hemodialysis Catheters Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Material
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Hemodialysis Catheters Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Material
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Hemodialysis Catheters Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Material
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea Hemodialysis Catheters Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Material
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan Hemodialysis Catheters Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Material
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Hemodialysis Catheters Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Material
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Hemodialysis Catheters Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Material
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Hemodialysis Catheters Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Material
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Hemodialysis Catheters Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Material
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Hemodialysis Catheters Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Material
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Hemodialysis Catheters Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Material
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Hemodialysis Catheters Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Material
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Hemodialysis Catheters Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Material
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Hemodialysis Catheters Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Material
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Manish Medi Innovation
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Advin Health Care
• 15.3. Medical Components, Inc.
• 15.4. Becton, Dickinson and Company
• 15.5. Tianck Medical Co., Ltd.
• 15.6. Mozarc Medical Holding LLC
• 15.7. Joline GmbH & Co. KG
• 15.8. Merit Medical Systems, Inc.
• 15.9. Teleflex Incorporated
• 15.10. B. Braun SE

16. Strategic Recommendations

17. About Us & Disclaimer